BC tumor-derived SEVs can induce an M1 proinflammatory response in macrophages through the activation of NFκB, which stimulates the production of inflammatory cytokines including GCSF, IL-6, IL-8, IL-1β, CCL2, and TNF-α [211]. This evidence concerns the gene CCL2 and breast cancer.